Massimo Pandolfo, MD, discusses the known molecular mechanisms that lead to Friedreich's ataxia: the decreased expression of the frataxin gene, mitochondrial iron accumulation and oxidative stress. Robert Wilson, MD, discusses the therapeutic pathways associated with each of these and the drugs being used to target them.
![](https://s2.save4k.ru/pic/kAE2OZNZCfU/mqdefault.jpg)